Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Graceway receives Canadian approval for topical genital warts treatment Vyloma 3.75%

March 24, 2011

Astellas' Protopic approved in Canada for prevention of eczema flares

Feb. 18, 2011

AMAG receives NON from Health Canada regarding Feraheme submission

Feb. 9, 2011

Health Canada approves Vyvanse for ADHD in adolescents and adults

Feb. 4, 2011

Prolia available in Quebec for postmenopausal osteoporosis

Feb. 3, 2011

DigiFab approved in Canada to treat digoxin toxicity/overdose

Feb. 1, 2011

Health Canada approves once-daily antidepressant Oleptro

Jan. 21, 2011

FDA and Health Canada grant telaprevir priority review for HCV infection

Jan. 21, 2011

Eli Lilly's Byetta is approved in Canada for type 2 diabetes

Jan. 19, 2011

Health Canada requests more information from Osiris regarding Prochymal approval

Jan. 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...